Azienda Unita Sanitaria Locale Di Modena

At Azienda Unita Sanitaria Locale Di Modena, the clinical trial portfolio in neoplasms focuses on several cancers, including breast cancer, prostate cancer, urothelial carcinoma, ovarian cancer, and small cell lung cancer. The studies are designed to test new treatment strategies, compare therapies, and improve outcomes for patients with advanced or high-risk disease.

• Testing targeted and endocrine-based approaches for early and high-risk breast cancer
• Evaluating treatment options for metastatic castration-resistant prostate cancer
• Assessing new combinations for bladder cancer and other urothelial cancers
• Exploring maintenance and supportive strategies in ovarian and lung cancer

These trials reflect a strong interest in improving cancer control through more personalized and effective therapies, with research supported by the hospital’s specialized gastrointestinal and endoscopic clinical environment.

Research in female urogenital diseases at this site includes studies on premature rupture of membranes during pregnancy, alongside cancer-related investigations affecting women, such as breast cancer and ovarian cancer. The main goal is to improve maternal and newborn outcomes while also refining treatment choices for women with complex oncologic conditions.

• Studying active management for pregnant patients with PROM
• Evaluating care strategies to reduce newborn respiratory support needs
• Supporting women with high-risk breast cancer through personalized treatment research

This mix of obstetric and oncologic research shows a broad commitment to women’s health, combining better diagnosis, treatment selection, and outcome improvement.

The site also conducts studies in investigative techniques and clinical decision support, including research on colonoscopy preparation and biomarker-guided treatment planning. These trials aim to make diagnostic procedures more effective and to help clinicians choose treatments more precisely.

• Comparing bowel cleansing options for elective colonoscopy
• Using gene-expression tools to guide adjuvant therapy decisions in breast cancer
• Assessing biomarkers that may predict response to platinum-based chemotherapy

At UO Gastroentrologia ed Endoscopia Digestiva, this line of research supports better procedure quality, more tailored care, and improved use of diagnostic information in everyday practice.